Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2004
11/24/2004EP1479395A1 Modified factor VII
11/24/2004EP1479391A1 Ex vivo cultured vital slices of mammalian heart tissue, methods for their production and culture as well as uses thereof
11/24/2004EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004EP1478769A2 Phytases, nucleic acids encoding them and methods for making and using them
11/24/2004EP1478762A2 Nucleic acid-associated proteins
11/24/2004EP1478761A1 Degradation of hydrophobic ester pesticides and toxins
11/24/2004EP1478759A1 Retroviral vectors pseudotyped with influenza virus hemagglutinin for gene delivery
11/24/2004EP1478753A1 Genetic sequences having methyltransferase activity and uses therefor
11/24/2004EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004EP1478745A2 Kinases and phosphatases
11/24/2004EP1478739A1 Process for sorting motile particles from lesser-motile particles and apparatus suitable therefor
11/24/2004EP1478738A1 Anti-ccr5 antibody
11/24/2004EP1478737A1 Cmos process-compatible high dielectric constant surface coating for the detection and stimulation of biological tissue
11/24/2004EP1478736A2 High-level production of amyloid-beta peptides from imr-32 cells
11/24/2004EP1478735A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/24/2004EP1478734A2 Serum-free media for chondrocytes and methods of use thereof
11/24/2004EP1478729A2 Device and method for cultivating tissue cells
11/24/2004EP1478667A1 Anti-human tenascin monoclonal antibody
11/24/2004EP1478659A2 Biologically active peptides
11/24/2004EP1478654A2 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES
11/24/2004EP1478388A1 Purification of red blood cells by separation and diafiltration
11/24/2004EP1478384A2 Method for increasing the survival of dopamine secreting cells
11/24/2004EP1478304A2 Pre-fabricated tissue-engineered plug
11/24/2004EP1478236A2 Targeted retrograde gene delivery to motor neurons
11/24/2004EP1416973A4 Modulation of mhc class i antigen presentation
11/24/2004EP1392859A4 Isolating cells expressing secreted proteins
11/24/2004EP1381625B1 Mutants of green fluorescent protein
11/24/2004EP1349582B1 Substrates containing polyphosphazene as matrix for cell culture
11/24/2004EP1303539B1 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
11/24/2004EP1282690B1 Isolation of precursor cells and their use for tissue repair
11/24/2004EP1279038B1 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
11/24/2004EP1276367A4 Novel 'oxy' cms brassica napus plant corrected for chlorosis using hexaploid bridging material generated through protoplast fusion
11/24/2004EP1274301B1 Novel warming method of cryopreserved specimens
11/24/2004EP1027014B1 Implantable system with drug-eluting cells for on-demand local drug delivery
11/24/2004EP1009754A4 Presenilin-1 gene promoter
11/24/2004EP1003840A4 Synthetic genes for plant gums
11/24/2004EP0873502B1 Method of isolating cells
11/24/2004EP0755449B1 DNA SEQUENCES CODING FOR A CYNNAMOYL CoA REDUCTASE AND THEIR USE IN THE REGULATION OF PLANT LIGNIN CONCENTRATIONS
11/24/2004CN1549862A Transgenic plants expressing cobalamin binding proteins
11/24/2004CN1549861A Method for secretory production of glycoprotein having human-type sugar chain using plant cell
11/24/2004CN1549860A Method for producing alpha-hydroxy acid, glycolic acid 2-hydroxyisobutyric acid from a corresponding alpha-hydroxy nitrile using nitrilase
11/24/2004CN1549858A Endogenous and non-endogenous versions of human G protein-coupled receptors
11/24/2004CN1549856A Method for differentiating mesenchymal stem cells into neural cells
11/24/2004CN1549829A Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use
11/24/2004CN1549826A Compositions and methods of treating diabetes
11/24/2004CN1549728A Immune composition containing antigen, gene vector and adjuvant
11/24/2004CN1549727A Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
11/24/2004CN1549721A Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
11/24/2004CN1548535A Method of establishing mouse genome mutant embryonic stem cell library
11/24/2004CN1548531A Cell system for generating somatic cells
11/24/2004CN1548530A Interaction and influence on proliferation of neure cell of BEX1, LMO2 and SNF5
11/24/2004CN1548529A Separation method of buffering stem cell in human placenta
11/24/2004CN1548528A Method of activating lvier stem cell
11/24/2004CN1548459A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
11/24/2004CN1548458A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
11/24/2004CN1177046C Enhanced virus-mediated DNA transfer
11/24/2004CN1177041C Method of utilizing three-dimensional rack seed cell double phase inoculation to construct engineered tissue
11/24/2004CN1177040C Plant cell engineering process of producing puerarin
11/24/2004CN1177030C Spatial cell electrofusion room
11/23/2004US6822141 Diacylglycerol acyl transferase proteins
11/23/2004US6822137 Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof
11/23/2004US6822083 TSA305 gene
11/23/2004US6822080 For identification/cloning/drug screening; enzyme inhibitors
11/23/2004US6822077 Altering ku80 levels in plants; recobinant expression cassettes
11/23/2004US6822072 For diagnostics/forensics/gene therapy/chromosome mapping; expression vector design/secretion
11/23/2004US6821782 Selecting an explant of living tissue from the plant and cultivating the tissue on a primary medium to produce totipotent tissue
11/23/2004US6821780 Complete nutrient medium for use as a cosmetic and cosmetic use thereof
11/23/2004US6821779 In medium lacking added buffer or added protein prior to transplantation; cryopreservation
11/23/2004US6821778 For adoptive cellular immunotherapy of infectious diseases/cancer
11/23/2004US6821777 Cell line preparing and producing ovine adenovirus vectors
11/23/2004US6821754 Staphylococcus aureus genes and polypeptides
11/23/2004US6821745 Regulation of human pyroglutamyl peptidase-like enzyme
11/23/2004US6821743 Membrane protein for use in controlling vasodilation
11/23/2004US6821742 Conformational and topological protein regulation
11/23/2004US6821741 Cells for detection of enteroviruses
11/23/2004US6821735 Protein involved in abscisic acid signalling
11/23/2004US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004US6821516 Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
11/23/2004US6821511 Transducing cell; incubate cells with nucleotide sequences, insert cells into mammals, monitor mammals for phenotypic adjustment
11/23/2004US6821510 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
11/23/2004US6821281 Microstructures for treating and conditioning skin
11/23/2004US6821107 Culturing; using alginate gel formed on porous membrane; forming extracellular matrix without using n-isopropyl-acrylamide
11/23/2004CA2294158C Natural antitumor or antiviral substances and use of the same
11/23/2004CA2241569C Methods for producing taxane-type diterpenes
11/23/2004CA2012482C Hepatitis c diagnostics and vaccines
11/23/2004CA1341465C Herbicide resistance in plants
11/18/2004WO2004099418A1 Fused protein
11/18/2004WO2004099403A1 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar.
11/18/2004WO2004099396A1 Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom
11/18/2004WO2004099395A2 A method for the generation of neural progenitor cells
11/18/2004WO2004099394A2 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system
11/18/2004WO2004099393A1 Method for storing tumor cells
11/18/2004WO2004099392A1 Transfection method for mammalian cells
11/18/2004WO2004099388A2 Cbl-b polypeptides, complexes and related methods
11/18/2004WO2004099387A2 siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS
11/18/2004WO2004099385A2 Telomere elongation
11/18/2004WO2004099364A2 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells
11/18/2004WO2004099363A2 Dermal micro organs, methods and apparatuses for producing and using the same
11/18/2004WO2004099253A1 Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46
11/18/2004WO2004099252A1 Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44